ArticleJournal of experimental & clinical cancer research : CR2019

Valproic acid exhibits anti-tumor activity selectively against EGFR/ErbB2/ErbB3-coexpressing pancreatic cancer via induction of ErbB family members-targeting microRNAs.

Tingting Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.